“The point of the bill is not to say, ‘Don’t use Ozempic’ or ‘You can’t use these drugs’,” Ms. Menin told CBS News. “It’s more to inform consumers of the serious side effects with these drugs.”
The commissioner would be responsible for publishing the guidance online and distributing it to both hospitals that are affiliated with NYC Health + Hospitals and hospitals in the city affiliated with other organizations. The materials would also have to include information on reductions in drug supply.
Next, the bill will move to the city’s Committee on Health for review.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
